By Drug Type
- Progestin
- Gonadotropins Releasing Hormone Agonists
- Oral Contraceptive Pills
- Non-Steroidal Anti-Inflammatory Drugs
By Distribution Channel
- Pain Management
- Hormonal Therapies
By Treatment Type
- Drug Stores
- Hospital Pharmacies
- Mail Order Pharmacies
- E-Pharmacies
- Retail Pharmacies
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
The market is categorised into drug type, distribution channel, treatment type and region. The drug type segment is bifurcated into progestin, gonadotropins releasing hormone agonists, oral contraceptive pills, non-steroidal ani-inflammatory drugs. The oral contraceptive pills segment is predicted to account the largest endometriosis treatment market share as it is a highly preferred treatment method owing to their efficacy of preventing the recurrence of endometriosis lesions and pelvic pain. But there are side effects of these pills like mood swings, elevated blood pressure and nausea. The progestins are required to be consumed intermittently unlike oral contraceptives that should be consumed regularly. The treatment segment is fragmented into pain management and hormonal therapies. The distribution channel segment is bifurcated into drug stores, hospital pharmacies, mail order pharmacies, e-pharmacies, retail pharmacies and others.
The North America region is predicted to dominate the market during the forecast period and this can be credited to the rising population capable of reproducing, increased patient number diagnosed with endometriosis, high losses owing to disability and key market players have a stronghold in the region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecasted timeframe owing to key market players expanding their businesses in the region.